Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chang'an No. 1 Formula (中药肠安Ⅰ号方) is a traditional Chinese medicine (TCM) herbal compound designed for the treatment of gastrointestinal disorders, particularly those involving intestinal inflammation and mucosal barrier dysfunction such as irritable bowel syndrome (IBS). While direct published data on "Chang'an No. 1" is limited in English-language sources, it appears to be part of a series of TCM formulas targeting gut health; related formulas like "Chang’an II" have demonstrated anti-inflammatory and immunomodulatory effects in preclinical models by repairing the intestinal mucosal barrier and modulating immune cell ratios and cytokine expression[2]. The mechanism of action is believed to involve multiple herbal components acting synergistically to reduce inflammation, restore immune balance in the gut mucosa (e.g., normalizing CD4+/CD8+ T-cell ratios), decrease pro-inflammatory cytokines such as IL-1β while increasing anti-inflammatory cytokines like IL-4[2]. The formula likely follows classical TCM principles for harmonizing liver and spleen function according to syndrome differentiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chang'an No. 1 Formula.